Efficacy and Safety of Glycopyrrolate/Formoterol Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Patients With COPD
Open Access
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- “Trying, But Failing” — The Role of Inhaler Technique and Mode of Delivery in Respiratory Medication AdherenceThe Journal of Allergy and Clinical Immunology: In Practice, 2016
- FLIGHT1 and FLIGHT2: Efficacy and Safety of QVA149 (Indacaterol/Glycopyrrolate) versus Its Monocomponents and Placebo in Patients with Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2015
- The 24-h lung-function profile of once-daily tiotropium and olodaterol fixed-dose combination in chronic obstructive pulmonary diseasePulmonary Pharmacology & Therapeutics, 2015
- Tiotropium and olodaterol fixed-dose combinationversusmono-components in COPD (GOLD 2–4)European Respiratory Journal, 2015
- Efficacy and safety of fixed-dose combinations of aclidinium bromide/formoterol fumarate: the 24-week, randomized, placebo-controlled AUGMENT COPD studyRespiratory Research, 2014
- Efficacy and safety of umeclidinium plus vilanterol versus tiotropium, vilanterol, or umeclidinium monotherapies over 24 weeks in patients with chronic obstructive pulmonary disease: results from two multicentre, blinded, randomised controlled trialsThe Lancet Respiratory Medicine, 2014
- Effect of QVA149 on lung volumes and exercise tolerance in COPD patients: The BRIGHT studyRespiratory Medicine, 2014
- Dual bronchodilation with QVA149versussingle bronchodilator therapy: the SHINE studyEuropean Respiratory Journal, 2013
- Combination bronchodilator therapy in the management of chronic obstructive pulmonary diseaseRespiratory Research, 2013
- Novel hydrofluoroalkane suspension formulations for respiratory drug deliveryExpert Opinion on Drug Delivery, 2005